Product Information


Targeted Relief for Better Patient Outcomes

Relief from chronic peripheral nerve pain is possible without drugs or invasive surgery when using a peripheral nerve stimulator (PNS) such as StimRouter. The StimRouter targets pain at its source. Its small profile allows the system to be implanted in many locations around the body, depending on patient needs.

An estimated 20% of US adults suffer from chronic pain and according to a report on chronic pain from the Center for Disease Control and Prevention, 8% of these patients have high-impact chronic pain that limits life or work activities on a nearly daily basis.

The process of chronic pain management is long and convoluted, including behavioral, pharmacologic, injections, and surgical options. Unfortunately, behavioral therapies rarely provide sufficient relief and opioids, which can be more effective, are highly addictive.

Neuromodulation has emerged as a proven method to target the nerves responsible for the patient’s pain. For more information including full prescribing information and clinical research, visit the StimRouter website.

Product Information


Pain Relief That Targets the Pain Directly in a Patient’s Joints

Osteoarthritis (OA) is the most common cause of knee and hip pain, causing sufferers significant pain while limiting their ability to lead active lives. Bioventus’ joint pain injection therapies are nonsurgical alternatives created to work with the body’s biological processes, providing a natural lubricant into the joint that relieve mild to moderate pain, improves mobility, and helps the patient get back to their normal activities.

Many OA patients find that their synovial joint fluid gets weaker as this chronic disease progresses. By injecting hyaluronic acid directly to affected areas, our therapies are able to restore the lubricating and shock-absorbing properties of joint fluid, which are normally depleted due to OA. Unlike the generalized relief experienced with oral painkillers, precise injection of HA therapy directly into the joint safely relieves pain from osteoarthritis and helps patients get back to their daily lives.

DUROLANE, GELSYN-3 and SUPARTZ FX can be administered right in a doctor’s office. The procedure only takes a few minutes, and most patients experience little or no discomfort during the injection.

For more information about how our joint injection therapies can bring the pain relief and mobility to the patient, including full prescribing information and clinical research, visit OAKneePainRelief.com.

Patient Assistance Program

Bioventus is committed to providing access to SUPARTZ FX, GELSYN-3 and DUROLANE to patients without the financial resources to pay for the treatment by providing Patient Assistance Product at no cost. Learn more

Product Information


XCELL PRP®: Designed for Precision and Efficiency in Platelet-Rich Plasma (PRP) Preparation

The XCELL PRP system is a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle.

The system offers leukocyte-rich and leukocyte-poor PRP preparations in one platform. Designed to capture the entire buffy coat, the system is engineered to provide consistent processing results.1

The XCELL PRP system delivers customized treatments from an advanced benchtop processing station with a hand-controlled dial.

Reference: 1. Apex Biologix. Data on file, DOC-0004, June 2025.

StimRouter is a registered trademark of Bioness, Inc. GELSYN-3, and DUROLANE are registered trademarks of Bioventus LLC. SUPARTZ FX is a registered trademark of Seikagaku Corp.